Translational Barriers to Pharmaceutical Excipient Readiness in Marine-Derived Polymers
Polymers · 11.05.2026 · 18 (10) · 1179
DOI: 10.3390/polym18101179 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Polymers, online erschienen am 11.05.2026. Verfasst von Yedi Herdiana und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang 45363, West Java, Indonesia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Padjadjaran University.
Abstract (Originalsprache)
Marine polymers have attracted a lot of attention as potential alternatives to the traditional animal-derived polymers in pharmaceutical formulation since they are abundant, biocompatible, and versatile in functionality. However, the presence of these materials in dosage-form studies, often in support of proof-of-concept trials, does not mean they are ready to apply as excipients routinely. This review critically evaluates the reasons why three of the most highly researched marine-derived polymers, chitosan, alginate, and carrageenan, continue to encounter significant translational barriers in pharmaceutical excipient development. All three polymers have been demonstrated to have clear pharmaceutical utility; however, their behavior is highly dependent on source, structure, processing history and formulation context. Chitosan explains why functional benefits may be compromised by responses to material requirements; alginate explains why apparent proximity to use may not remove composition-related variability; and carrageenan explains that even seemingly simple rheological functions may be very context-dependent. All of this points to the fact that the major hurdle lies not in the lack of potential, but in the difficulty of achieving the required degree of control, reproducibility, and manufacturability in order to make the reliable use of excipients possible. Future progress in this field will likely require a shift from descriptive exploration toward readiness-focused evidence, including demonstrated control over material attributes, reproducible performance, and feasible qualification pathways.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang 45363, West Java, Indonesia.
- Department of Pharmaceutical Technology, Faculty of Pharmacy, Universiti Malaya, Kuala Lumpur 50603, Malaysia.
- Faculty of Medicine, Universiti Malaya Research Centre for Biopharmaceuticals and Advanced Therapeutics (UBAT), Universiti Malaya, Kuala Lumpur 50603, Malaysia.
- Centre of Advanced Materials (CAM), Faculty of Engineering, Universiti Malaya, Kuala Lumpur 50603, Malaysia.
- Faculty of Pharmaceutical Sciences, Chulalongkorn University, Pathum Wan, Bangkok 10330, Thailand.
- Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang 45363, West Java, Indonesia.
ORCID-Profile: Yedi Herdiana, Ferry Ferdiansyah Sofian
Förderung
- Padjadjaran University
Zitieren
APA
Herdiana, Y., Mahmood, S., Halimah, E., & Sofian, F. F. (2026). Translational Barriers to Pharmaceutical Excipient Readiness in Marine-Derived Polymers. Polymers, 18(10), 1179. https://doi.org/10.3390/polym18101179
Vancouver
Herdiana Y, Mahmood S, Halimah E, Sofian FF. Translational Barriers to Pharmaceutical Excipient Readiness in Marine-Derived Polymers. Polymers. 2026;18(10):1179. doi:10.3390/polym18101179
BibTeX
@article{Herdiana2026,
author = {Herdiana, Yedi and Mahmood, Syed and Halimah, Eli and Sofian, Ferry Ferdiansyah},
title = {Translational Barriers to Pharmaceutical Excipient Readiness in Marine-Derived Polymers},
journal = {Polymers},
year = {2026},
volume = {18},
number = {10},
pages = {1179},
doi = {10.3390/polym18101179}
}
EUVIMED